Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Hui Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9722-2619; OpenAlex author ID A5100423847. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. Pancreatic Cancer-Targeting Cascade Nanoamplifier Enables Self-Replenishing H2O2 Generation and Autophagy Disruption in Chemodynamic Therapy. Last author DOI 10.3390/pharmaceutics17091201↗
  2. Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s10142-023-01020-4↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuan Ji Ma · 1 shared paper, 2025 · strength 0.28
  2. Jiaqi Yu · 1 shared paper, 2025 · strength 0.28
  3. Yee Lin Tang · 1 shared paper, 2025 · strength 0.28
  4. Xueli Zhang · 1 shared paper, 2023 · strength 0.16
  5. Yingna Liao · 1 shared paper, 2023 · strength 0.16
  6. Shan Zhang · 1 shared paper, 2023 · strength 0.16
  7. Yan-Zhi Gai · 1 shared paper, 2023 · strength 0.16
  8. Xiaomei Yang · 1 shared paper, 2023 · strength 0.16
  9. Hui Nie · 1 shared paper, 2023 · strength 0.16
  10. Shu‐Heng Jiang · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.